Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Research article

Factors influencing survival time of hemodialysis patients; time to event analysis using parametric models: a cohort study

Authors: Vahid Ebrahimi, Mohammad Hossein Khademian, Seyed Jalil Masoumi, Mohammad Reza Morvaridi, Shahrokh Ezzatzadegan Jahromi

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Survival analysis of patients on maintenance hemodialysis (HD) has been the subject of many studies. No study has evaluated the effect of different factors on the survival time of these patients. In this study, by using parametric survival models, we aimed to find the factors affecting survival and discover the effect of them on the survival time.

Methods

As a retrospective cohort study, we evaluated the data of 1408 HD patients. We considered the data of patients who had at least 3 months of HD and started HD from December 2011 to February 2016. The data were extracted from Shiraz University of Medical Sciences (SUMS) Special Diseases database. Primary event was death. We applied Cox-adjusted PH to find the variables with significant effect on risk of death. The effect of various parameters on the survival time was evaluated by a parametric survival model, the one found to have the best fit by Akaike Information Criterion (AIC).

Results

Of 428 HD patients eligible for the analysis, 221 (52%) experienced death. With the mean ± SD age of 60 ± 16 years and BMI of 23 ± 4.6 Kg/m, they comprised of 250 men (58%). The median of the survival time (95% CI) was 624 days (550 to 716). The overall 1, 2, 3, and 4-year survival rates for the patients undergoing HD were 74, 42, 25, and 17%; respectively. By using AIC, AFT log-normal model was recognized as the best functional form of the survival time. Cox-adjusted PH results showed that the amount of ultrafiltration volume (UF) (HR = 1.146, P = 0.049), WBC count (HR = 1.039, P = 0.001), RBC count (HR = 0.817, P = 0.044), MCHC (HR = 0.887, P = 0.001), and serum albumin (HR = 0.616, P < 0.001) had significant effects on mortality. AFT log-normal model indicated that WBC (ETR = 0.982, P = 0.018), RBC (ETR = 1.131, P = 0.023), MCHC (ETR = 1.067, P = 0.001), and serum albumin (ETR = 1.232, 0.002) had significant influence on the survival time.

Conclusion

Considering Cox and three parametric event-time models, the parametric AFT log-normal had the best efficiency in determining factors influencing HD patients survival. Resulting from this model, WBC and RBC count, MCHC and serum albumin are factors significantly affecting survival time of HD patients.
Literature
1.
go back to reference Kleinbaum DG, Klein M. Survival analysis. New York: Springer-Verlag; 2010;3. Kleinbaum DG, Klein M. Survival analysis. New York: Springer-Verlag; 2010;3.
2.
go back to reference Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York: Springer-Verlag; 2005. Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York: Springer-Verlag; 2005.
3.
go back to reference Altman D, De Stavola B, Love S, Stepniewska K. Review of survival analyses published in cancer journals. Br J Cancer. 1995;72(2):511.CrossRef Altman D, De Stavola B, Love S, Stepniewska K. Review of survival analyses published in cancer journals. Br J Cancer. 1995;72(2):511.CrossRef
4.
go back to reference Nardi A, Schemper M. Comparing cox and parametric models in clinical studies. Stat Med. 2003;22(23):3597–610.CrossRef Nardi A, Schemper M. Comparing cox and parametric models in clinical studies. Stat Med. 2003;22(23):3597–610.CrossRef
5.
go back to reference Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, Safaee A, Abadi A, Zali MR. Comparing cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev. 2007;8(3):412.PubMed Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, Safaee A, Abadi A, Zali MR. Comparing cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev. 2007;8(3):412.PubMed
6.
go back to reference Carroll KJ. On the use and utility of the Weibull model in the analysis of survival data. Control Clin Trials. 2003;24(6):682–701.CrossRef Carroll KJ. On the use and utility of the Weibull model in the analysis of survival data. Control Clin Trials. 2003;24(6):682–701.CrossRef
7.
go back to reference Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205–13.PubMed Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205–13.PubMed
8.
go back to reference Müller M. Goodness-of-fit criteria for survival data. In: Discussion paper//Sonderforschungsbereich 386 der Ludwig-Maximilians-Universität München; 2004. Müller M. Goodness-of-fit criteria for survival data. In: Discussion paper//Sonderforschungsbereich 386 der Ludwig-Maximilians-Universität München; 2004.
9.
go back to reference Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in cox regression. Stat Med. 1995;14(15):1707–23.CrossRef Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in cox regression. Stat Med. 1995;14(15):1707–23.CrossRef
10.
go back to reference Fan J, Li R: Variable selection for Cox's proportional hazards model and frailty model. Annals of Statistics 2002;30:74–99. Fan J, Li R: Variable selection for Cox's proportional hazards model and frailty model. Annals of Statistics 2002;30:74–99.
11.
go back to reference Orbe J, Ferreira E, Núñez-Antón V. Comparing proportional hazards and accelerated failure time models for survival analysis. Stat Med. 2002;21(22):3493–510.CrossRef Orbe J, Ferreira E, Núñez-Antón V. Comparing proportional hazards and accelerated failure time models for survival analysis. Stat Med. 2002;21(22):3493–510.CrossRef
12.
go back to reference Wang SJ, Kalpathy-Cramer J, Kim JS, Fuller CD, Thomas Jr CR: Parametric survival models for predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer. In: AMIA Annual Symposium Proceedings: 2010. American Medical Informatics Association; 2010: 847. Wang SJ, Kalpathy-Cramer J, Kim JS, Fuller CD, Thomas Jr CR: Parametric survival models for predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer. In: AMIA Annual Symposium Proceedings: 2010. American Medical Informatics Association; 2010: 847.
13.
go back to reference Hsu CW, Lin JL, Lin-Tan DT, Yen TH, Chen KH. White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients. Ther Apher Dial. 2010;14(6):552–9.CrossRef Hsu CW, Lin JL, Lin-Tan DT, Yen TH, Chen KH. White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients. Ther Apher Dial. 2010;14(6):552–9.CrossRef
14.
go back to reference Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O'shea S, Owen WF Jr, Lowrie EG. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003;18(6):1167–73.CrossRef Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O'shea S, Owen WF Jr, Lowrie EG. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003;18(6):1167–73.CrossRef
15.
go back to reference Michel BE. The association of red blood cell parameters with mortality in a population of hemodialysis patients. Dial Transplant. 2011;40(2):72–7.CrossRef Michel BE. The association of red blood cell parameters with mortality in a population of hemodialysis patients. Dial Transplant. 2011;40(2):72–7.CrossRef
16.
go back to reference Tennankore KK, Soroka SD, West KA, Kiberd BA: Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study. BMC Nephrol 2011;12:19. Tennankore KK, Soroka SD, West KA, Kiberd BA: Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study. BMC Nephrol 2011;12:19.
17.
go back to reference Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005;20(9):1880–8.CrossRef Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant. 2005;20(9):1880–8.CrossRef
18.
go back to reference Mafra D, Farage NE, Azevedo DL, Viana GG, Mattos JP, Velarde LGC, Fouque D. Impact of serum albumin and body-mass index on survival in hemodialysis patients. Int Urol Nephrol. 2007;39(2):619–24.CrossRef Mafra D, Farage NE, Azevedo DL, Viana GG, Mattos JP, Velarde LGC, Fouque D. Impact of serum albumin and body-mass index on survival in hemodialysis patients. Int Urol Nephrol. 2007;39(2):619–24.CrossRef
Metadata
Title
Factors influencing survival time of hemodialysis patients; time to event analysis using parametric models: a cohort study
Authors
Vahid Ebrahimi
Mohammad Hossein Khademian
Seyed Jalil Masoumi
Mohammad Reza Morvaridi
Shahrokh Ezzatzadegan Jahromi
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1382-2

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue